Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about IONS
Recent news which mentions IONS
< Previous
1
2
3
4
5
Next >
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
October 31, 2024
Tickers
ADPT
ARKG
ARKK
CDNA
Tags
HOOD
Broad U/S/ Equity ETFs
Specialty ETFs
From
Benzinga
Deep Dive Into Ionis Pharmaceuticals Stock: Analyst Perspectives (13 Ratings)
September 26, 2024
Tickers
IONS
Tags
Analyst Ratings
Market News
IONS
From
Benzinga
Rubrik Reports Q2 Results, Joins Ionis Pharmaceuticals, Hewlett Packard Enterprise And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
September 10, 2024
Tickers
APLD
DBX
EXTR
HPE
Tags
APLD
big gainers
Market News
From
Benzinga
Why Oracle Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
September 10, 2024
Tickers
AMZN
ASNS
AVO
CNET
Tags
News
Movers
SGLY
From
Benzinga
What 14 Analyst Ratings Have To Say About Ionis Pharmaceuticals
August 26, 2024
Tickers
IONS
Tags
Market News
Analyst Ratings
IONS
From
Benzinga
12 Analysts Have This To Say About Ionis Pharmaceuticals
August 02, 2024
Tickers
IONS
Tags
IONS
BZI/AAR
Benzinga
From
Benzinga
Ionis' Rare Development Disorder Drug Candidate 'Could Be Differentiated' From Peer Ultragenyx: Analyst
July 22, 2024
Tickers
ALNY
AZN
BIIB
IONS
Tags
Health Care
BIIB
Biotech
From
Benzinga
The Latest Analyst Ratings For Ionis Pharmaceuticals
July 16, 2024
Tickers
IONS
Tags
Benzinga
IONS
BZI/AAR
From
Benzinga
Assessing Ionis Pharmaceuticals: Insights From 6 Financial Analysts
June 27, 2024
Tickers
IONS
Tags
Benzinga
IONS
BZI/AAR
From
Benzinga
RXO, Alnylam Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session
June 24, 2024
Tickers
ALNY
ALT
ARGX
CLOV
Tags
UPS
CLOV
big gainers
From
Benzinga
Deep Dive Into Ionis Pharmaceuticals Stock: Analyst Perspectives (6 Ratings)
June 03, 2024
Tickers
IONS
Tags
Analyst Ratings
Market News
Benzinga
From
Benzinga
Ionis Pharmaceuticals Reveals Late-Stage Donidalorsen Data, Analyst Says Results Show Competitive Hereditary Angioedema Profile
May 31, 2024
Tickers
IONS
NEWS
Tags
News
Briefs
IONS
From
Benzinga
Europe Approves Biogen's Tofersen For Adult Patients With Rare Type Of Neurodegenerative Disorder
May 31, 2024
Tickers
BIIB
IONS
NEWS
Tags
IONS
General
Health Care
From
Benzinga
Tale Of Two Ionis-Partnered Neurology-Focused Early Stage Assets-Biogen Discontinues One, Decides Not To Exercise Licensing Option For Another
May 16, 2024
Tickers
BIIB
IONS
NEWS
Tags
BIIB
Health Care
Equities
From
Benzinga
The 3 Most Undervalued Pharma Stocks to Buy in May 2024
May 09, 2024
Tickers
BIIB
IONS
SNY
Tags
IONS
BIIB
SNY
From
InvestorPlace
The Analyst Landscape: 8 Takes On Ionis Pharmaceuticals
May 08, 2024
Tickers
IONS
Tags
Analyst Ratings
Market News
Benzinga
From
Benzinga
IONS Stock Earnings: Ionis Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024
May 07, 2024
Tickers
IONS
Tags
Earnings Reports
IONS
NASDAQ:IONS
From
InvestorPlace
The Latest Analyst Ratings For Ionis Pharmaceuticals
April 09, 2024
Tickers
IONS
Tags
Analyst Ratings
Market News
BZI/AAR
From
Benzinga
Genetic Medicines Focused-Ionis Pharmaceuticals' Fatty Liver Candidate Lowers Excess Liver Fat, Midstage Study Data Shows
March 13, 2024
Tickers
IONS
NEWS
Tags
Large Cap
Biotech
Health Care
From
Benzinga
Cracking The Code: Understanding Analyst Reviews For Ionis Pharmaceuticals
February 22, 2024
Tickers
IONS
Tags
Market News
Analyst Ratings
Benzinga
From
Benzinga
Earnings Scheduled For February 21, 2024
February 21, 2024
Tickers
ACVA
ADI
AGI
AGR
Tags
HVT
ESEA
CAKE
From
Benzinga
JP Morgan Maintains Neutral Rating for Ionis Pharmaceuticals: Here's What You Need To Know
February 01, 2024
Tickers
IONS
Tags
Market News
Analyst Ratings
Benzinga
From
Benzinga
Biogen Gives Up On Aduhelm Efforts After Two Years Of Controversial FDA Accelerated Approval For Alzheimer's, Shifts Focus On Newer Medicines
January 31, 2024
Tickers
BIIB
IONS
NEWS
Tags
BIIB
General
Health Care
From
Benzinga
Rare Disease Focused Ionis Pharmaceuticals Gears Up for FDA Submission After Donidalorsen Outperforms Placebo In Swollen Vessels Study
January 22, 2024
Tickers
IONS
NEWS
Tags
Health Care
Equities
Biotech
From
Benzinga
Expert Outlook: Ionis Pharmaceuticals Through The Eyes Of 8 Analysts
January 18, 2024
Tickers
IONS
Tags
IONS
BZI/AAR
Benzinga
From
Benzinga
2024 And Beyond – Exploring Six Investment Megatrends With Tema ETFs
January 04, 2024
Tickers
ALNY
ARM
CPRI
IONS
Tags
Financials
Specialized Finance
Partner Content
From
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
January 02, 2024
Tickers
ABBV
ALNY
CVS
GILD
Tags
IONS
BZI/AUOA
ALNY
From
Benzinga
3 Stocks to Buy Now Before They Become Tomorrow’s Trillion-Dollar Companies
December 27, 2023
Tickers
IONS
TSM
UNH
Tags
TSM
Market News
Stocks to Buy
From
InvestorPlace
Pricing Projections And Market Potential For Ionis' Newly Approved Nerve Damage Drug - Analyst Sees Over $700M Potential
December 22, 2023
Tickers
ALNY
AZN
IONS
NEWS
Tags
Reiteration
Expert Ideas
Analyst Color
From
Benzinga
New Hope for Nerve Damage Patients as AstraZeneca/Ionis' Eplontersen Receives FDA Nod for Hereditary Amyloidosis Treatment
December 22, 2023
Tickers
AZN
IONS
NEWS
Tags
Health Care
AZN
Large Cap
From
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.